Technical Analysis for RPTX - Repare Therapeutics Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 3.29 | -2.08% | -0.07 |
RPTX closed up 3.07 percent on Tuesday, April 23, 2024, on 1.38 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
Earnings due: May 7
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| MACD Bullish Signal Line Cross | Bullish | -2.08% | |
| Pocket Pivot | Bullish Swing Setup | -2.08% | |
| NR7 | Range Contraction | -2.08% | |
| Wide Bands | Range Expansion | -2.08% | |
| Up 3 Days in a Row | Strength | -2.08% | |
| Oversold Stochastic | Weakness | -2.08% | |
| Wide Bands | Range Expansion | 0.92% | |
| Oversold Stochastic | Weakness | 0.92% | |
| Pocket Pivot | Bullish Swing Setup | 4.44% | |
| New 52 Week Low | Weakness | 4.44% |
| Alert | Time |
|---|---|
| Down 2 % | 6 minutes ago |
| Possible NR7 | 21 minutes ago |
| Possible Inside Day | 21 minutes ago |
| Down 1% | about 2 hours ago |
| 60 Minute Opening Range Breakdown | about 3 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/07/2024
Repare Therapeutics is a leading precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics. The Company utilizes its genome-wide, CRISPR-enabled SNIPRx® platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage repair. The Company’s pipeline includes its lead product candidate RP-3500, a potential leading ATR inhibitor, as well as CCNE1-SL inhibitor and Polθ inhibitor programs.
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Genetics Precision Medicine Cancer Therapies Genome CRISPR Synthetic Lethality
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Genetics Precision Medicine Cancer Therapies Genome CRISPR Synthetic Lethality
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 13.85 |
| 52 Week Low | 2.98 |
| Average Volume | 127,560 |
| 200-Day Moving Average | 7.07 |
| 50-Day Moving Average | 5.21 |
| 20-Day Moving Average | 3.86 |
| 10-Day Moving Average | 3.43 |
| Average True Range | 0.33 |
| RSI (14) | 29.58 |
| ADX | 46.81 |
| +DI | 9.42 |
| -DI | 31.38 |
| Chandelier Exit (Long, 3 ATRs) | 4.38 |
| Chandelier Exit (Short, 3 ATRs) | 3.97 |
| Upper Bollinger Bands | 4.92 |
| Lower Bollinger Band | 2.80 |
| Percent B (%b) | 0.26 |
| BandWidth | 54.85 |
| MACD Line | -0.58 |
| MACD Signal Line | -0.59 |
| MACD Histogram | 0.0116 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 3.65 | ||||
| Resistance 3 (R3) | 3.64 | 3.53 | 3.60 | ||
| Resistance 2 (R2) | 3.53 | 3.46 | 3.54 | 3.58 | |
| Resistance 1 (R1) | 3.45 | 3.42 | 3.49 | 3.46 | 3.57 |
| Pivot Point | 3.34 | 3.34 | 3.37 | 3.35 | 3.34 |
| Support 1 (S1) | 3.26 | 3.27 | 3.30 | 3.27 | 3.15 |
| Support 2 (S2) | 3.15 | 3.23 | 3.16 | 3.14 | |
| Support 3 (S3) | 3.07 | 3.15 | 3.12 | ||
| Support 4 (S4) | 3.08 |
